nice work @MoneyLover91, Will be looking out for an acceleration of press coverage over the next few weeks. From Business News Australia this afternoon:
https://www.businessnewsaus.com.au/articles/joint-telehealth-development-to-assist-in-diagnosing-respiratory-disease.html
Two digital health companies have joined forces to expand access to telehealth services targeted specifically at diagnosing respiratory diseases. ResApp Health (ASX: RAP) will integrate its acute respiratory diagnostic test ResAppDx-EU into Phenix Health's telehealth smartphone app.
The partnership is a significant step toward accelerating diagnosis and treatment of respiratory diseasesconsidering users of Phenix Health's app no longer have to rely on additional hardware; diagnosis can occur entirely within a single telehealth session. By using machine learning algorithms ResAppDx-EU analyses patients' cough sounds to diagnose lower respiratory tract diseases such as pneumonia and asthma exacerbations.
Ultimately, the partnership will enable doctors to determine whether a patient should attend a hospital or clinic for additional care, thus conserving already strained healthcare resources.
With people around the world encouraged to remain at home as much as possible telehealth technology is becoming a vital tool to help slow the spread of the novel coronavirus, enabling sick patients to see a doctor at a distance, away from those most vulnerable in the broader community.
Ann: ResAppDx-EU to be Deployed on Phenix Health Telehealth App, page-88
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #